SCHEMBL7464430

SCHEMBL7464430

NC1CCC(N2CCN(c3cccc(Cl)c3)CC2)CC1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
MAPT P10636 1/20 0.55
ALOX12 P18054 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
POLB P06746 1/20 0.53
HTR1A P08908 2/20 0.52
HTR2A P28223 2/20 0.52
HTR7 P34969 2/20 0.52
HTR6 P50406 2/20 0.52
HTR3E A5X5Y0 2/20 0.50
HTR3B O95264 2/20 0.50
HTR3A P46098 2/20 0.50
HTR3D Q70Z44 2/20 0.50
HTR3C Q8WXA8 2/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
ADRB1 P08588 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7897428 1.00 ALDH1A1 (0.55) ALDH1A1LMNAMAPTALOX12SMN1; SMN2
SCHEMBL3965782 0.86 POLB (0.67) ALDH1A1LMNAMAPTALOX12SMN1; SMN2
SCHEMBL7464308 0.85 POLB (0.53) ALDH1A1LMNAMAPTALOX12SMN1; SMN2
SCHEMBL7898571 0.85 POLB (0.53) ALDH1A1LMNAMAPTALOX12SMN1; SMN2
SCHEMBL13698475 0.85 POLB (0.65) ALDH1A1LMNAMAPTALOX12SMN1; SMN2
SCHEMBL20129679 0.84 ALDH1A1 (0.60) ALDH1A1LMNAMAPTALOX12SMN1; SMN2
SCHEMBL7473599 0.82 POLB (0.53) ALDH1A1LMNAMAPTALOX12SMN1; SMN2
SCHEMBL372411 0.81 GRIN2B (0.65) ALDH1A1MAPTTHRBCYP2C9CYP2C19
SCHEMBL372412 0.81 GRIN2B (0.65) ALDH1A1MAPTTHRBCYP2C9CYP2C19
SCHEMBL861784 0.81 GRIN2B (0.65) ALDH1A1MAPTTHRBCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1023273-B1 CYCLOHEXANE DERIVATIVES DIFUNCTIONALISED IN 1,4 AS LIGANDS OF 5HT1A RECEPTORS PF MEDICAMENT (FR) 2002-06-05 EP disclosed
US-6191130-B1 HYPOTENSIVE AGENTS; THERAPY FOR SEXUAL DISORDERS; CENTRAL NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS PIERRE FABRE MEDICAMENT (FR) 2001-02-20 US disclosed
EP-1023273-A1 CYCLOHEXANE DERIVATIVES DIFUNCTIONALISED IN 1,4 AS LIGANDS OF 5T H1A RECEPTORS PIERRE FABRE MEDICAMENT (FR) 2000-08-02 EP disclosed
WO-1999020613-A1 CYCLOHEXANE DERIVATIVES DIFUNCTIONALISED IN 1,4 AS LIGANDS OF 5T H1A RECEPTORS PIERRE FABRE MEDICAMENT (FR) 1999-04-29 WO disclosed